MedTrace Logo

Ibuprofen Suspension Bioequivalence Study

NCT02503085 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2018-04-13

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to determine the rate and extent of absorption of Ibuprofen suspension formulations.

Conditions

  • Healthy Volunteer Study

Interventions

DRUG

Nurofen for Children®

DRUG

Algifor Dolo Junior®

Sponsors & Collaborators

  • Reckitt Benckiser Healthcare (UK) Limited

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-02
Primary Completion
2015-08-25
Completion
2015-08-25

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02503085 on ClinicalTrials.gov